Drug intelligence / Profile preview

ketoprofen + baclofen + amitriptyline + lidocaine

Development stage
Preclinical
Lead developer
KAZM Pharmaceuticals
Modality
Small Molecules
Administration
Topical
01

Overview

This is a **compounded topical pharmaceutical formulation** combining four active ingredients: - **Ketoprofen** (a non-steroidal anti-inflammatory drug, NSAID) reduces pain and inflammation through inhibition of cyclooxygenase enzymes and prostaglandin synthesis. - **Baclofen** (a muscle relaxant and antispastic agent) acts primarily as a GABA-B receptor agonist, inhibiting spinal reflexes and reducing muscle spasticity or neuropathic pain. - **Amitriptyline** (a tricyclic antidepressant) inhibits reuptake of serotonin and norepinephrine, modulates pain transmission, and reduces neuropathic pain. - **Lidocaine** (a local anesthetic) blocks voltage-gated sodium channels, stabilizing neuronal membranes and reducing peripheral nerve pain. This combination is designed for topical use in the treatment of **chronic localized pain syndromes**—including neuropathic pain and musculoskeletal pain—where conventional therapies have failed or are poorly tolerated. This formulation is custom-compounded in compounding pharmacies; it is not a mass-produced, branded pharmaceutical.

Other names
ketoprofen + baclofen + amitriptyline + lidocaine
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)SERT (Sodium-dependent serotonin transporter)NET (Norepinephrine Transporter)GABA-B (Gamma-aminobutyric acid receptor type B)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on ketoprofen + baclofen + amitriptyline + lidocaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ketoprofen + baclofen + amitriptyline + lidocaine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call